Neoclease Awarded Merck’s 2025 North American Advance Biotech Grant for Pioneering Gene-Editing Therapies Targeting Parkinson’s Disease Merck, a globally recognized leader in science and technology, has officially announced that Neoclease, an emerging biotech startup based in Boston, has been selected…
Brenntag and ExxonMobil Deepen White Oils Partnership Across EMEA Brenntag, the global leader in chemicals and ingredients distribution, has announced a significant expansion of its long-standing distribution agreement with ExxonMobil for White Oils. This collaboration, which has flourished for decades…
Volt Lithium to Launch Mobile Direct Lithium Extraction Unit in North Dakota’s Bakken Basin Volt Lithium Corp. ansition to LibertyStream Infrastructure Partners has announced the final assembly and imminent deployment of its proprietary mobile Direct Lithium Extraction (DLE) unit in…
Hibiki Path Advisors Finalizes Voting Position on Key Proposals at Japan Pure Chemical’s 54th AGM Hibiki Path Advisors (“we” or “us”) has now formalized its voting policy regarding several significant agenda items at the upcoming 54th Annual General Meeting (“AGM”)…
Graham Corporation, a global leader in engineering and manufacturing mission-critical technologies in fluid handling, power, heat transfer, and vacuum systems for the Defense, Energy & Process, and Space sectors, has released its financial results for the fourth quarter and the…
IMCD Strengthens Iberian Presence with Strategic Acquisition of Ferrer Alimentación and Medir Ferrer IMCD N.V a global leader in the distribution and formulation of specialty chemicals and ingredients, has taken a significant step forward in strengthening its footprint in the…
FDA Grants New Approval for Bayer’s Nubeqa™ (Darolutamide) in Treating Advanced Prostate Cancer Bayer today announced a significant milestone in the treatment of prostate cancer, revealing that the U.S. Food and Drug Administration (FDA) has approved an expanded use of…
Bayer’s Sevabertinib (BAY 2927088) Receives FDA Priority Review for HER2-Mutant Non-Small Cell Lung Cancer FDA Bayer has announced that its investigational compound, sevabertinib (BAY 2927088), has been granted Priority Review status by the U.S. Food and Drug Administration (FDA) for…
Pimicotinib Shows Promising Phase 3 Results in Treating Tenosynovial Giant Cell Tumor (TGCT) Merck, a global leader in science and technology, has released detailed findings from Part 1 of its global Phase 3 MANEUVER trial. The study evaluated the investigational…
Global Specialty Carbon Black Market Forecast (2025–2034): Trends, Segmentation, and Strategic Insights The global specialty carbon black market is poised for significant growth between 2025 and 2034, driven by its expanding role in high-performance applications across industries such as plastics,…
Merck Unveils Comprehensive Oncology Advances at ASCO 2025, Targeting Advanced Cancers and Rare Tumors Merck, a global leader in science and technology innovation, today announced the presentation of a broad spectrum of new clinical data across more than a dozen…
PTT Global Chemical (GC) Reports Strong Q1 2025 Recovery, Doubling Adjusted EBITDA and Advancing Toward Sustainable, Resilient Growth PTT Global Chemical Public Company Limited (GC) has announced its financial and operational performance for the first quarter of 2025, revealing a…